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Background
The Cambodian National Influenza Center (NIC) was
established in August 2006 for the purpose of document-
ing the dynamics of influenza disease and to virologically
characterize the circulating strains. To continuously
monitor influenza activity, a hospital-based sentinel sur-
veillance system for ILI (influenza-like illness) with a
weekly reporting and sampling scheme was initially
established in five sites in 2006. In addition, hospital-
based surveillance of acute lower respiratory infection
(ALRI) cases was established in 2 sites.
Methods
The sentinel sites collected weekly epidemiological
data from patients who fulfilled the ILI case definition,
and took naso-pharyngeal specimens from 5 to 10
cases per week. Over 4100 respiratory samples were
collected from hospitalized ALRI patients between
2007 and 2010. All samples were tested in the Virology
Unit at the Institut Pasteur in Phnom Penh. Viral RNA
was extracted and amplified by a multiplex RT-PCR
detecting influenza A and influenza B virus simulta-
neously. Influenza A viruses were then subtyped and
analyzed by hemagglutination inhibition assay. The
susceptibility to neuraminidase inhibitor drugs (oselta-
mivir, and zanamivir) was determined using the NA-
STAR kit (Applied Biosystems®). Genetic analyses
targeting HA, NA, and M genes were conducted on
strains selected randomly.
Results
We observed that 5.8% (30 of 516), 7.7% (96 of 1250),
15.3% (212 of 1382), 15.2% (909 of 6011) and 1.4% (25
of 1791) of overall clinical specimens were positive for
influenza virus in the years 2006, 2007, 2008, 2009 and
2010 respectively. Until 2009, H3N2 virus was always
the predominant influenza A sub-type detected: 100%
in 2006, 65.9 % in 2007, 81.3% in 2008. No influenza B
viruses were isolated in 2006 but accounted for 57.7%
and 34% of all influenza strains in 2007 and 2008,
respectively. Pandemic H1N1 (H1N1pdm) was first
detected in Cambodia in August 2009 and subse-
quently replaced the seasonal H1N1 strain as the most
frequently detected subtype. However, H3N2 continued
to co-circulate in significant proportions through
November 2009. Antigenic analyses show that seasonal
H1N1 belonged to the groupsA / N e wC a l e d o n i a / 2 0 /
1999-like in 2007 and A/Brisbane/59/2007-like in
2008. H3N2 belonged to A/Wisconsin/67/2005-like in
2006 and 2007, and to A/Brisbane/10/2007-like in
2008 and 2009. The influenza B strains drifted from B/
Malaysia/2506/2004-like in 2007 to B/Florida/4/2006-
like in 2008 and then to B/Brisbane/60/2008-like in
2009. Sequences of the M gene obtained from repre-
sentative 2007-2008 H1N1 and H3N2 strains contained
the S31N mutation associated with adamantanes resis-
tance. Except for a single H1N1 strain detected in
2007, no reduction in the susceptibility to neuramini-
dase inhibitors was observed among the influenza virus
circulating from 2007 to 2010. Each year, the peak of
influenza circulation was observed mainly from August
to November. The proportion of specimens collected
from patients with ILI which tested positive for Influ-
enza virus varied between 0% (in May) and 51% (in
October). In contrast, only 5 to 10% of the ALRI speci-
mens were positive for influenza virus during peak of
seasonal transmission. Since 2007, 4 new human cases
of influenza A/H5N1 infection have been identified but
by different surveillance systems (event-based surveil-
lance, fever study)
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Peak seasonal influenza activity in Cambodia occurred
during the rainy season from August to November.
Although Cambodia is a tropical country geographically
located in the northern hemisphere, influenza activity
has a southern hemisphere transmission pattern. There-
fore, while the northern hemisphere vaccine may pro-
vide partial protection in Cambodia, the southern
hemisphere vaccine is recommended. The drug suscept-
ibility profile of Cambodian influenza strains revealed
that neuraminidase inhibitors would be the drug of
choice for influenza treatment and chemoprophylaxis in
Cambodia, as adamantanes are no longer expected to be
effective.
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